Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
Crit Care
.
2018 Apr 16;22(1):96.
doi: 10.1186/s13054-018-2006-0.
Authors
Nina Buchtele
1
,
Michael Schwameis
2
,
Bernd Jilma
3
Affiliations
1
Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
2
Department of Emergency Medicine, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
3
Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria. bernd.jilma@meduniwien.ac.at.
PMID:
29661216
PMCID:
PMC5902841
DOI:
10.1186/s13054-018-2006-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Angiotensin II*
Humans
Shock*
Vasoconstrictor Agents
Substances
Vasoconstrictor Agents
Angiotensin II